WILLKOMMEN BEI GENERALI INVESTMENTS

WEBSITE WECHSELN

Diaman Awards

Generali Obligations Internationales wurde als „Best Performing Fund in 2016” mit dem Diaman Award in der Kategorie “Fund of Fund Fixed Income“ ausgezeichnet.

About Generali Investments

Generali Investments, the main asset manager of the Generali Group, offers a broad choice of personalised investment solutions for institutional and private clients, ranging from institutional mandates to mutual funds. With more than €455 billion of assets under management at the end of 2016 (source: Generali Investments Europe S.p.A. Società di gestione del risparmio), Generali Investments is one of the largest asset managers in Europe (sources: IPE, Generali Investments Europe S.p.A. Società di gestione del risparmio, December 2016). The company has developed proven expertise in multi-asset portfolio management, adopting a method based on research and a prudent risk approach to protect invested capital and deliver stable longterm yields. Generali Investments is a commercial brand of Generali Investments Europe S.p.A. Società di gestione del risparmio, an Italian asset management company with its registered office at 34132, Trieste, 4, via Machiavelli, Italy, registered at the Albo delle Società di Gestione del Risparmio in the UCITS Section, under no. 18 and in the AIF section, under no. 22 and subject to the direction and coordination of Generali Investments Holding S.p.A.

Media Relations Generali Investments

T +39.02.60765762

T +39.02.72504213

media@generali-invest.com

Related Insights

  • fb
  • tw
  • in
Investment View Q4 2018 - The next shoe to drop

28/09/2018

There will be plenty of icebergs to navigate in Q4, such as the trade war (continued), the Italian ructions, US mid-term elections and final A50 negotiations.

Read More
  • fb
  • tw
  • in
GENERALI SMART FUNDS FIDELITY WORLD FUND

25/09/2018

JETZT ANSEHEN
  • fb
  • tw
  • in
Generali Investments SRI Newsletter 16th issue, July 2018

13/07/2018

In this issue of SRI-highlight, we decided to look “under the bonnet” and illustrate through the Pharmaceutical & Healthcare sector how our SRI analysts typically conduct a sector review, what are the key criteria they focus their attention on and what is the outcome of that review for portfolio managers and, ultimately, for our investors.

JETZT ANSEHEN